Abstract
Even following optimal local therapy of soft-tissue sarcomas, about half of all patients will experience treatment failure and ultimately succumb. The recurrence may be local/regional or at distant metastatic sites, but either problem will often require a therapeutic effort to achieve patient comfort. These patterns of treatment failure will be addressed individually.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Benjamin RS, Baker LH, Rodriguez V, Moon TE, O’Bryan RM, Stephens RL, Sinkovics JG, Thigpen T, Kind GW, Bottomley R, Groppe CW, Bodey GP, Gottlieb JA: The chemotherapy of soft tissue sarcomas in adults. In Management of Primary Bone and Soft Tissue Tumors. Chicago, Year Book Medical Publishers, 1977, pp 309 – 316.
Benjamin RS, Wiernik PH, Bachur NR: Adriamycin: a new effective agent in the therapy of disseminated sarcomas. Med Pediatr Oncol 1: 63 – 76, 1975.
Beretta G, Bonadonna G, Bajetta E, Tancini G, DeLena M, Azzarelli A, Veronesi U: Combination chemotherapy with DTIC (NSC–45388) in advanced malignant melanoma, soft tissue sarcomas, and Hodgkin’s disease. Cancer Treat Rep 60:205– 211, 1976.
Beretta G, Fraschini P, Tedeschi L: Chemotherapy of soft tissue sarcomas. Oncology 37 (Suppl 1): 92 – 96, 1980.
Blum RH, Corson JM, Wilson RE, Greenberger JS, Canellos GP, Frei E: Successful treatment of metastatic sarcomas with cyclophosphamide, adriamycin, and DTIC (CAD). Cancer 46: 1722 – 1726, 1980.
Borden E, Ash A, Rosenbaum C, Lerner H: Phase II evaluation of dibromodulcitol (DBD), ICRF 159, and maytansine for sarcomas. Am J Clin Oncol 5: 417 – 420, 1982.
Bramwell VHC, Brugasolas A, Mouridsen HT, Cheix F, DeJager R, van Oosterom AT, Vendrik CP, Pinedo HM, Sylvester R, DePauw M: E.O.R.T.C. phase II study of cisplatin in cyvadic-resistant soft tissue sarcoma. Eur J Cancer 15:1511– 1513, 1979.
Brenner DE, Chang P, Wiernik PH: Doxorubicin and dactinomycin therapy for advanced sarcomas. Cancer Treat Rep 65: 231 – 236, 1981.
Brenner J, Magill GB, Sordillo PP, Chang EW, Yagoda A: Phase II trial of cisplatin (CPDD) in previously treated patients with advanced sarcoma. Cancer 50: 2031 – 2033, 1982.
Bryant BM, Wiltshaw E: Results of the Royal Marsden Hospital second soft tissue sarcoma schedule (STS II) chemotherapy regimen in the management of advanced sarcomas. Cancer Treat Rep 64: 689 – 692, 1980.
Chang AE, Schaner EG, Conkle DM, Flye MW, Doppman JL, Rosenberg SA: Evaluation of computed tomography in the detection of pulmonary metastases: a prospective study. Cancer 43: 913 – 916, 1979.
Cormier WJ, Hahn RG, Edmonson JH, Eagan RT: Phase II study in advanced sarcoma: randomized trial of pyrazofurin versus combination cyclophosphamide, doxorubicin, and eis-dichlordiamminplatinum (II) (CAP). Cancer Treat Rep 64: 655 – 658, 1980.
Creagan ET, Edmonson JH, Hahn RG, Ahmann DL, Bisel HF, Eagan RT: A preliminary study of cyclophosphamide (NSC–26271), adriamycin (NSC–123127), imidazole carboxamide (NSC–45388), and actinomycin D (NSC–3053) with or without MER-BCG in patients with advanced sarcomas. Med Pediatr Oncol 4: 85 – 86, 1978.
Creagan ET, Fleming TR, Edmonson JH, Pairolero PC: Pulmonary resection for metastatic non-osteogenic sarcoma. Cancer 44: 1908 – 1912, 1979.
Creagan ET, Hahn RG, Ahmann DL, Edmonson JH, Bisel HF, Eagan RT: A comparative clinical trial evaluating the combination of adriamycin, DTIC, and vincristine, the combination of actinomycin D, cyclophosphamide, and vincristine, and a single agent, methyl-CCNU, in advanced sarcomas. Cancer Treat Rep 30: 1385 – 1387, 1976.
Dalley DN, Levi J A, Nesbitt RA, Tattersall MHN, Woods RL, Fox RM, Aroney RS: Cyclical combination chemotherapeutic regimen in adult soft tissue sarcoma. Cancer Clin Trials 4: 163 – 165, 1981.
Giuliano AE, Eilber FR, Morton DL: The management of locally recurrent soft- tissue sarcoma. Ann Surg 196: 87 – 91, 1982.
Gottlieb JA, Baker LH, O’Brien RM, Sinkovics JG, Hoogstraten B, Quagliana JM, Rivkin SE, Bodey GP, Rodriguez VT, Blumenschein GR, Saiki JH, Coltman C, Burgess MA, Sullivan P, Thigpen T, Bottomley R, Bakerzak S, Moon TE: Adriamycin (NSC–123127) used alone and in combination for soft tissue and bony sarcomas. Cancer Chemother Rep 6: 271 – 282, 1975.
Gottlieb JA, Baker LH, Quagliana JM, Luce JK, Whitecar JP, Sinkovics JG, Rivkin SE, Brownlee R, Frei E: Chemotherapy of sarcomas with a combination of adriamycin and dimethyl triazeno imidazole carboxamide. Cancer 30:1632– 1638, 1972.
Gottlieb JA, Benjamin RS, Baker LH, O’Bryan RM, Sinkovics JG, Hoogstraten B, Quagliana JM, Rivkin SE, Bodey GP, Rodriguez V, Blumenschein GR, Saiki JH, Coltman C, Burgess MA, Sullivan P, Thigpen T, Bottomley R, Balcerzak S, Moon TE: Role of DTIC (NSC–45388) in the chemotherapy of sarcomas. Cancer Treat Rep 60: 199 – 203, 1976.
Huang MN, Edgerton F, Takita H, Douglass HO, Karakousis C: Lung resection for metastatic sarcoma. Am J Surg 135: 804 – 806, 1978.
Huth JF, Holmes EC, Vernon SE, Callery CD, Ramming KP, Morton DL: Pulmonary resection for metastatic sarcoma. Am J Surg 140: 9 – 16, 1980.
Joseph WL, Morton DL, Adkins PC: Variation in tumor doubling time in patients with pulmonary metastatic disease. J Surg Oncol 3: 143 – 149, 1971.
Karakousis CP, Rao U, Carlson M: High-dose methotrexate as secondary chemotherapy in metastatic soft-tissue sarcomas. Cancer 46: 1345 – 1348, 1980.
Kaufman JH, Catane R, Douglass HO: Combined adriamycin, vincristine, and methotrexate in advanced, adult, soft-tissue sarcoma. NY State J Med 77:742– 743, 1977.
Luce JK, Thurman WG, Isaacs BL, Talley RW: Clinical trials with the antitumor agent 5–(3,3–dimethyl-l-triazeno) imidazole–4–carboxamide (NSC–45388). Cancer Chemother Rep 54: 119 – 124, 1970.
Lynch G, Magill GB, Sordillo P, Golbey RB: Combination chemotherapy of advanced sarcomas in adults with “CYOMAD” (S7). Cancer 50: 1724 – 1727, 1982.
Mavligit GM, Benjamin R, Patt YZ, Jaffe N, Chuang V, Wallace S, Murray J, Ayala A, Johnston S, Hersh EM, Calvo DB: Intraarterial cisplatinum for patients with inoperable skeletal tumors. Cancer 48: 1 – 4, 1981.
McCormack PM, Martini N: The changing role of surgery for pulmonary metastases. Ann Thorac Surg 28: 139 – 145, 1979.
Morrow CE, Vassilopoulos PP, Grage TB: Surgical resection for metastatic neoplasms of the lung: experience at the University of Minnesota Hospitals. Cancer 45: 2981 – 2985, 1980.
Morton DL, Joseph WL, Ketcham AS, Geelhoed GW, Adkins PC: Surgical resection and adjunctive immunotherapy for selected patients with multiple pulmonary metastases. Ann Surg 178: 360 – 366, 1973.
Mouridsen HT, Bramwell VHC, Lacave J, Metz R, Vendrik C, Hild J, McCrean- ney J, Sylvester R: Treatment of advanced soft tissue sarcomas with chlorozotocin: a phase II trial of the EORTC soft tissue and bone sarcoma group. Cancer Treat Rep 65: 509 – 511, 1981.
Neifeld JP, Michaelis LL, Doppman JL: Suspected pulmonary metastases: correlation of chest x-ray, whole lung tomograms, and operative findings. Cancer 39:383— 387, 1977.
Pinedo HM, Kenis Y: Chemotherapy of advanced soft tissue sarcomas in adults. Cancer Treat Rev 4: 67 – 86, 1977.
Presant CA, Bartolucci AA: Phase II trial of piperazinedione in metastatic sarcoma. Am J Clin Oncol 5: 185 – 187, 1982.
Presant CA, Lowenbraun S, Bartolucci AA, Smalley RV: Metastatic sarcomas: chemotherapy with adriamycin, cyclophosphamide and methotrexate alternating with actinomycin D, DTIC, and vincristine. Cancer 47: 457 – 465, 1981.
Rivkin SE, Gottlieb JA, Thigpen T, el Mawla NG, Saiki J, Dixon DO: Methyl CCNU and adriamycin for patients with metastatic sarcomas: a Southwest Oncology Group Study. Cancer 46: 446 – 451, 1980.
Saiki JH, Baker LH, Stephens RL, Fabian CJ, Kraut EH, Fletcher WS: Gallium nitrate in advanced soft tissue and bone sarcomas: a southwest oncology group study. Cancer Treat Rep 66: 1673 – 1674, 1982.
Savlov ED, Maclntyre JM, Knight E, Wolter J: Comparison of doxorubicin with cycloleucine in the treatment of sarcomas. Cancer Treat Rep 65: 21 – 27, 1981.
Schoenfeld DA, Rosenbaum C, Horton J, Wolter JM, Falkson G, DeConti RC: A comparison of adriamycin versus vincristine and adriamycin, and cyclophosphamide versus vincristine, actinomycin D, and cyclophosphamide for advanced sarcoma. Cancer 50: 2757 – 2762, 1982.
Sordillo PP, Magill GB, Gralla RJ: Chlorozotocin: phase II evaluation in patients with advanced sarcomas. Cancer Treat Rep 65: 513 – 514, 1981.
Sordillo PP, Magill GB, Gralla RJ: Phase II evaluation of vindesine sulfate in patients with advanced sarcomas. Cancer Treat Rep 65: 515 – 516, 1981.
Sordillo PP, Magill GB, Gralla RJ, Golbey RB: Phase II evaluation of 4’-(9– acridinylamino)-methanesulfon-m-anisidide (AMSA) in patients with advanced sarcoma. Cancer Treat Rep 64: 1129 – 1130, 1980.
Subramanian S, Wiltshaw E: Chemotherapy of sarcoma: a comparison of three regimens. Lancet 1: 683 – 686, 1978.
Sutow WW, Maurer HM: Chemotherapy of sarcomas—a perspective. Semin Oncol 8: 207 – 214, 1981.
Takita H, Edgerton F, Merrin C, Douglass HO, Karakousis C: Management of multiple lung metastases. J Surg Oncol 12: 199 – 205, 1979.
Wilkins EW, Head JM, Burke JF: Pulmonary resection for metastatic neoplasms in the lung: experience at the Massachusetts General Hospital. Am J Surg 135:480— 483, 1978.
Wiltshaw E: Methotrexate in treatment of sarcomata. Br Med J 2: 142 – 145, 1967.
Yap B-S, Baker LH, Sinkovics JG, Rivkin SE, Bottomley R, Thigpen T, Burgess MA, Benjamin RS, Bodey GP: Cyclophosphamide, vincristine, adriamycin, and DTIC (CYVADIC) combination chemotherapy for the treatment of advanced sarcomas. Cancer Treat Rep 64: 93 – 98, 1980.
Yap B-S, Benjamin RS, Burgess MA, Murphy WK, Sinkovics JG, Bodey GP: A phase II evaluation of methyl-CCNU and actinomycin D in the treatment of advanced sarcomas in adults. Cancer 47: 2807 – 2809, 1981.
Yap BS, Plager C, Benjamin RS, Murphy WK, Legha SS, Bodey GP: Phase II evaluation of AMSA in adult sarcomas. Cancer Treat Rep 65: 341 — 343, 1981.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1983 Springer-Verlag New York Inc.
About this chapter
Cite this chapter
Lawrence, W., Neifeld, J.P., Terz, J.J. (1983). Management of Recurrent and Metastatic Sarcoma. In: Manual of Soft-Tissue Tumor Surgery. Comprehensive Manuals of Surgical Specialties. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-5556-7_12
Download citation
DOI: https://doi.org/10.1007/978-1-4612-5556-7_12
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4612-5558-1
Online ISBN: 978-1-4612-5556-7
eBook Packages: Springer Book Archive